These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11159615)

  • 1. Thiazolidinediones for type 2 diabetes. No evidence exists that pioglitazone induces hepatic cytochrome P450 isoform CYP3A4.
    Glazer NB; Cheatham WW
    BMJ; 2001 Jan; 322(7280):235-6. PubMed ID: 11159615
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment: troglitazone drug interactions.
    Terra SG; Washam JB; May DB
    Ann Pharmacother; 1998 Oct; 32(10):1111. PubMed ID: 9793611
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment: troglitazone.
    Fraser CG; Fierro L
    Ann Pharmacother; 1998 Oct; 32(10):1111-2. PubMed ID: 9793612
    [No Abstract]   [Full Text] [Related]  

  • 4. [Glitazones. Profile of a new class of substances].
    Janka HU
    Internist (Berl); 2001 Apr; 42(4):587-96. PubMed ID: 11326741
    [No Abstract]   [Full Text] [Related]  

  • 5. Pioglitazone: effect on CYP3A4 activity.
    Nowak SN; Edwards DJ; Clarke A; Anderson GD; Jaber LA
    J Clin Pharmacol; 2002 Dec; 42(12):1299-302. PubMed ID: 12463723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors.
    Jaakkola T; Laitila J; Neuvonen PJ; Backman JT
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):44-51. PubMed ID: 16867170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glitazone--a new drug for type 2 diabetes].
    Toyota T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():422-8. PubMed ID: 12387028
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatotoxicity with thiazolidinediones: is it a class effect?
    Scheen AJ
    Drug Saf; 2001; 24(12):873-88. PubMed ID: 11735645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New drug overview. Pioglitazone hydrochloride.
    Am J Health Syst Pharm; 2000 Jan; 57(2):124-5. PubMed ID: 10688239
    [No Abstract]   [Full Text] [Related]  

  • 10. Pioglitazone: a review of Japanese clinical studies.
    Baba S
    Curr Med Res Opin; 2001; 17(3):166-89. PubMed ID: 11900311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical efficacy of Pioglitazone (AD-4833)].
    Kaneko T; Baba S
    Nihon Rinsho; 1997 Nov; 55 Suppl():142-6. PubMed ID: 9434458
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pioglitazone].
    Kobayashi M; Iwata M; Hiratani K
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():429-37. PubMed ID: 12387029
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics and clinical efficacy of pioglitazone.
    Hanefeld M
    Int J Clin Pract Suppl; 2001 Sep; (121):19-25. PubMed ID: 11594240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes.
    Yamazaki H; Shibata A; Suzuki M; Nakajima M; Shimada N; Guengerich FP; Yokoi T
    Drug Metab Dispos; 1999 Nov; 27(11):1260-6. PubMed ID: 10534310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study.
    Takagi T; Yamamuro A; Tamita K; Yamabe K; Katayama M; Mizoguchi S; Ibuki M; Tani T; Tanabe K; Nagai K; Shiratori K; Morioka S; Yoshikawa J
    Am Heart J; 2003 Aug; 146(2):E5. PubMed ID: 12891212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new era in type 2 diabetes mellitus treatment?
    Laws A
    Am J Med; 2001 Jul; 111(1):71-2. PubMed ID: 11448665
    [No Abstract]   [Full Text] [Related]  

  • 17. Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinide.
    Kajosaari LI; Jaakkola T; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2006 Mar; 62(3):217-23. PubMed ID: 16447051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of drug induced liver injury related pioglitazone].
    Hisamochi A; Kumashiro R; Koga Y; Tanaka E; Ide T; Hino T; Murashima S; Ogata K; Kuwahara R; Koga H; Shishido S; Ueno T; Sata M; Eguchi T
    Nihon Shokakibyo Gakkai Zasshi; 2003 Mar; 100(3):333-6. PubMed ID: 12696176
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA approves pioglitazone for diabetes.
    Miller JL
    Am J Health Syst Pharm; 1999 Sep; 56(17):1698. PubMed ID: 10512494
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanisms and clinical effects of pioglatizone as a new agent for the treatment of type-2 diabetes].
    Paul M
    Arzneimittelforschung; 1999 Oct; 49(10):835-42. PubMed ID: 10554661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.